Heptagon Fund plc - Driehaus US Small Cap Equity Fund C USD Acc

Register to Unlock Ratings
Performance History28/02/2021
Growth of 1,000 (GBP) Advanced Graph
Heptagon Fund plc - Driehaus US Small Cap Equity Fund C USD Acc
Fund---55.110.4
+/-Cat---31.62.9
+/-B’mrk---38.91.3
 
Key Stats
NAV
04/03/2021
 USD 168.14
Day Change -4.55%
Morningstar Category™ US Small-Cap Equity
ISIN IE00BH3ZBB87
Fund Size (Mil)
04/03/2021
 USD 395.43
Share Class Size (Mil)
04/03/2021
 USD 181.88
Max Initial Charge 3.00%
Ongoing Charge
19/02/2020
  1.47%
Investment Objective: Heptagon Fund plc - Driehaus US Small Cap Equity Fund C USD Acc
The investment objective of the Fund is to achieve long-term capital growth.
Returns
Trailing Returns (GBP)04/03/2021
YTD3.24
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Jeffrey James
31/07/2019
Inception Date
31/07/2019
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Russell 2000 Growth TR USDRussell 2000 TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNo
OtherNot Specific
Portfolio Profile for  Heptagon Fund plc - Driehaus US Small Cap Equity Fund C USD Acc31/01/2021
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock95.030.0095.03
Bond0.000.000.00
Property0.000.000.00
Cash4.970.004.97
Other0.000.000.00
Top 5 Regions%
United States95.22
Canada2.42
United Kingdom0.71
Europe - Emerging0.66
Asia - Emerging0.53
Top 5 Sectors%
Healthcare25.70
Technology23.02
Industrials16.38
Consumer Cyclical15.45
Financial Services6.74
Top 5 HoldingsSector%
Invitae CorpHealthcareHealthcare2.39
Natera IncHealthcareHealthcare2.08
Springworks Therapeutics Inc Ord... HealthcareHealthcare2.00
Sitime Corp Ordinary SharesTechnologyTechnology1.90
Relay Therapeutics Inc Ordinary ... HealthcareHealthcare1.85
Heptagon Fund plc - Driehaus US Small Cap Equity Fund C USD Acc

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies